seed
Stage
2024
Founded
1
Investors
About
Developer of a diagnostics technology platform that combines Liquid Chromatography-Mass Spectrometry (LC-MS) biomarker testing with machine learning analytics to reshape chronic disease management and rheumatoid arthritis care.
Explore Rheumasense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.